Sutro Biopharma, Inc

111 Oyster Point Blvd
South San Francisco
United States

Tel: 650.881.6500


2022 Best Places to Work
2023 Best Places to Work
2024 Best Places to Work
Featured Employer
Show jobs for this employer

About Sutro Biopharma, Inc



Sutro Biopharma, Inc., is a clinical-stage company relentlessly focused on the discovery and development of precisely designed cancer therapeutics, transforming what science can do for patients. Sutro’s fit-for-purpose technology, including cell-free XpressCF®, provides the opportunity for broader patient benefit and an improved patient experience. Sutro has multiple clinical stage candidates, including luveltamab tazevibulin, or luvelta, a registrational-stage folate receptor alpha (FolRα)-targeting ADC in clinical studies. A robust pipeline, coupled with high-value collaborations and industry partnerships, validates our continuous product innovation. Sutro is headquartered in South San Francisco. For more information, follow Sutro on social media @Sutrobio, or visit

Stock Symbol: STRO




Bill Newell, CEO Interviewed by Brad Loncar, Founder, Biotech TV – “Sutro Biopharma’s CEO on ADCs, non-cell protein synthesis, and more" - view it here 



Our Sutro Story

196 articles about Sutro Biopharma, Inc